{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,8]],"date-time":"2025-10-08T22:45:24Z","timestamp":1759963524443},"reference-count":41,"publisher":"Wiley","issue":"2","license":[{"start":{"date-parts":[[2005,5,24]],"date-time":"2005-05-24T00:00:00Z","timestamp":1116892800000},"content-version":"vor","delay-in-days":843,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Journal of the American Academy of Nurse Practitioners"],"published-print":{"date-parts":[[2003,2]]},"abstract":"<jats:sec><jats:title>Purpose<\/jats:title><jats:p>To describe the pathophysiology, assessment, diagnosis, and management of interstitial cystitis.<\/jats:p><\/jats:sec><jats:sec><jats:title>Data Sources<\/jats:title><jats:p>Selected professional publications and presentations.<\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusions<\/jats:title><jats:p>Interstitial cystitis (1C) is a chronic and disabling condition. Symptoms include urinary frequency and urgency, pain, dyspareunia, and nocturia. It occurs primarily in women. Onset is predominately in adulthood although 1C does occur in childhood. Bladder wall defects, auto\u2010immune disorder, viral and\/or bacterial infection, toxin exposure, pelvic floor dysfunction and inflammatory response are possible causes. Diagnosis is by history, physical examination, laboratory tests, and cystoscopic examination. The management of interstitial cystitis includes dietary changes, antihistamines, tri\u2010cyclic antidepressants, oral and intravesicle glu\u2010cosaminoglycans, hydrodistention, pain management and emotional support.<\/jats:p><\/jats:sec><jats:sec><jats:title>Implications for Practice<\/jats:title><jats:p>Nurse practitioners need to be knowledgeable about the occurrence and debilitating effect of IC. Inclusion of IC into the differential diagnoses related to urgency, frequency, and abdominal pain will help assure the timely and effective diagnosis and management of this unusual disease.<\/jats:p><\/jats:sec>","DOI":"10.1111\/j.1745-7599.2003.tb00353.x","type":"journal-article","created":{"date-parts":[[2005,5,24]],"date-time":"2005-05-24T14:14:22Z","timestamp":1116944062000},"page":"64-71","source":"Crossref","is-referenced-by-count":11,"title":["Interstitial Cystitis"],"prefix":"10.1111","volume":"15","author":[{"given":"Grace","family":"Newsome","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"311","published-online":{"date-parts":[[2005,5,24]]},"reference":[{"key":"e_1_2_1_2_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0090-4295(99)80332-X"},{"key":"e_1_2_1_3_1","unstructured":"Alberts G.L Strata C.W. Mitchell W.M. &Franke J.J.(2001 June).Potential role of chlamydia pneumoniae in the pathogenesis of interstitial cystitis. Paper presented at the American Urological Association. Anaheim CA."},{"key":"e_1_2_1_4_1","doi-asserted-by":"crossref","unstructured":"Azevedo K. &Payne C.K.(2000 October).The psychosocial economic impact of invisible chronic disease: Examining the experiences of clients with interstitial cystitis. Poster session presented at the NIDDK\/ICA Symposium on Interstitial Cystitis & Bladder Research Minneapolis MN.","DOI":"10.1016\/S0090-4295(01)01065-2"},{"issue":"6","key":"e_1_2_1_5_1","first-page":"155","volume":"12","author":"Batra A.","year":"1999","journal-title":"Interstitial cystitis. Infectious Urology"},{"key":"e_1_2_1_6_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0022-5347(05)66099-5"},{"key":"e_1_2_1_7_1","doi-asserted-by":"crossref","unstructured":"Bouchelouche K. Nordling J. Hald T &Bouchelouche P.(2000 October).Treatment of interstitial cystitis with montelukast (singulair) a leukotriene D4 receptor antagonist. Poster session presented at the NIDDK\/ICA Symposium on Interstitial Cystitis & Bladder Research Minneapolis MN.","DOI":"10.1016\/S0090-4295(01)01066-4"},{"key":"e_1_2_1_8_1","doi-asserted-by":"crossref","first-page":"1786","DOI":"10.1016\/S0022-5347(05)68800-3","article-title":"The urinary glycoprotein GP51 as a clinical marker for interstitial cystitis","volume":"161","author":"Byrne D.S.","year":"1999","journal-title":"Journal of Urology"},{"key":"e_1_2_1_9_1","doi-asserted-by":"crossref","unstructured":"Caraballo R. Bologna R.A. Lukban J. &Whitmore K.E.(2000 October).Sacral nerve stimulation as a treatment for urge incontinence and associated pelvic floor disorders at a pelvic floor center: A follow\u2010up study. Poster session presented at the NIDDK\/ICA Symposium on Interstitial Cystitis & Bladder Research Minneapolis MN.","DOI":"10.1016\/S0090-4295(01)01073-1"},{"key":"e_1_2_1_10_1","first-page":"34","article-title":"Supratrigonal cystectomy and ileocystoplasty in management of interstitial cystitis. Aust. N.Z. J","volume":"70","author":"Costello A.J.","year":"2000","journal-title":"Surgery"},{"key":"e_1_2_1_11_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0022-5347(01)61947-5"},{"key":"e_1_2_1_12_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0022-5347(05)65517-6"},{"key":"e_1_2_1_13_1","doi-asserted-by":"publisher","DOI":"10.1089\/152460999319075"},{"key":"e_1_2_1_14_1","unstructured":"Feloney M.P. &Culkin D.J.(2001 June).Neuromodulation treatment for refractory severe interstitial cystitis. Paper presented at the2001American Urological Association meeting Anaheim CA."},{"key":"e_1_2_1_15_1","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1016\/S0094-0143(21)00596-6","article-title":"Amitriptyline in the treatment of interstitial cystitis","volume":"21","author":"Hanno P.M.","year":"1994","journal-title":"Urology Clinics of North America"},{"key":"e_1_2_1_16_1","first-page":"631","volume-title":"Campbell's Urology","author":"Hanno P.M.","year":"1998"},{"key":"e_1_2_1_17_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0022-5347(01)61948-7"},{"key":"e_1_2_1_18_1","doi-asserted-by":"publisher","DOI":"10.1097\/00007611-200002000-00021"},{"key":"e_1_2_1_19_1","volume-title":"Primary Care for Women","author":"Howard EM.","year":"1997"},{"key":"e_1_2_1_20_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0090-4295(97)00110-6"},{"key":"e_1_2_1_21_1","article-title":"Disability report writing made easier","volume":"2","author":"Interstitial Cystitis Association","year":"1999","journal-title":"ICA Physician Perspectives"},{"key":"e_1_2_1_22_1","unstructured":"Interstitial Cystitis Association (unknown date). 1C and over\u2010the\u2010counter products and medications. Retrieved 12\/14\/01 fromhttp:\/\/www.ichelp.org\/TreatmentAndSelfHelp\/OTCProductsAndMeds.html."},{"key":"e_1_2_1_23_1","doi-asserted-by":"crossref","unstructured":"Keay S. Zhang C. O. Marvel R.&Chai T.(2000 October).Antiproliferative factor (AFP) Heparin\u2010binding epidermal growth factor\u2010like growth factor (HB\u2010EGF) and epidermal growth factor (EGF)\u2010Sensitive and specific urine markers for interstitial cystitis (1C). Paper presented at the NIDDK\/ICA Symposium on Interstitial Cystitis & Bladder Research Minneapolis MN.","DOI":"10.1016\/S0090-4295(01)01028-7"},{"issue":"1","key":"e_1_2_1_24_1","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1016\/S0094-0143(21)00587-5","article-title":"Epidemiology of interstitial cystitis","volume":"21","author":"Koziol J.A.","year":"1994","journal-title":"Urologic Clinics of North America"},{"issue":"7","key":"e_1_2_1_25_1","first-page":"1199","article-title":"Interstitial cystitis: Urgency and frequency syndrome","volume":"64","author":"Metts J.F.","year":"2001","journal-title":"American Family Physician"},{"key":"e_1_2_1_26_1","volume-title":"The Interstitial Cystitis Survival Guide","author":"Moldwin R.M.","year":"2000"},{"key":"e_1_2_1_27_1","unstructured":"Mosbaugh P.G.(2000).Current update on oral and intravesicle therapies for chronic interstitial cystitis. Interstitial Cystitis Association. Retrieved on December 14 01 from.http:\/\/www.ichelp.org\/FeatureArticles\/MosbaughChroniclC.html."},{"key":"e_1_2_1_28_1","unstructured":"National Institute of Diabetes and Digestive and Kidney Diseases(1994).Interstitial Cystitis. Rockville Md. U.S. Department of Health and Human Services Public Health Service National Institutes of Health. NIH publication no. 94\u20133220."},{"key":"e_1_2_1_29_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0022-5347(05)67134-0"},{"key":"e_1_2_1_30_1","doi-asserted-by":"crossref","unstructured":"Nordling J. Jorgensen S. &Kallestrup E.(2000 October).Cystistat for the treatment of interstitial cystitis (1C): A 3\u2010year follow\u2010up study. Poster session presented at the NIDDK\/ICA Symposium on Interstitial Cystitis & Bladder Research Minneapolis MN.","DOI":"10.1016\/S0090-4295(01)01079-2"},{"key":"e_1_2_1_31_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0022-5347(05)67203-5"},{"key":"e_1_2_1_32_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0090-4295(99)00162-4"},{"key":"e_1_2_1_33_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0022-5347(05)66093-4"},{"key":"e_1_2_1_34_1","doi-asserted-by":"publisher","DOI":"10.1097\/00006254-199805000-00023"},{"key":"e_1_2_1_35_1","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1016\/S0094-0143(21)00590-5","article-title":"The role of the mast cell in interstitial cystitis","volume":"21","author":"Sant G.R.","year":"1994","journal-title":"Urology Clinics of North America"},{"key":"e_1_2_1_36_1","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1016\/S0094-0143(21)00594-2","article-title":"Standard intravesical therapies for interstitial cystitis","volume":"21","author":"Sant G.R.","year":"1994","journal-title":"Urology Clinics of North America"},{"key":"e_1_2_1_37_1","doi-asserted-by":"crossref","unstructured":"Schuster G.A.(2000 October).Interstitial cystitis in childrenoNot a rare entity. Paper presented presented at the NIDDK\/ICA Symposium on Interstitial Cystitis & Bladder Research Minneapolis MN.","DOI":"10.1016\/S0090-4295(01)01034-2"},{"key":"e_1_2_1_38_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0090-4295(94)80074-X"},{"key":"e_1_2_1_39_1","unstructured":"Steers W.D.(2000 October).Interstitial cystitis: Past and future. Paper presented at the NIDDK\/ICA Symposium on Interstitial Cystitis & Bladder Research Minneapolis MN."},{"key":"e_1_2_1_40_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0090-4295(97)00182-9"},{"key":"e_1_2_1_41_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0022-5347(05)65539-5"},{"issue":"1","key":"e_1_2_1_42_1","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1016\/S0094-0143(21)00601-7","article-title":"Self\u2010care regimens for clients with interstitial cystitis","volume":"21","author":"Whitmore K.E.","year":"1994","journal-title":"Urology Clinics of North America"}],"container-title":["Journal of the American Academy of Nurse Practitioners"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/j.1745-7599.2003.tb00353.x","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/j.1745-7599.2003.tb00353.x","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,9,11]],"date-time":"2023-09-11T06:12:18Z","timestamp":1694412738000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/j.1745-7599.2003.tb00353.x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2003,2]]},"references-count":41,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2003,2]]}},"alternative-id":["10.1111\/j.1745-7599.2003.tb00353.x"],"URL":"https:\/\/doi.org\/10.1111\/j.1745-7599.2003.tb00353.x","archive":["Portico"],"relation":{},"ISSN":["1041-2972","1745-7599"],"issn-type":[{"value":"1041-2972","type":"print"},{"value":"1745-7599","type":"electronic"}],"subject":[],"published":{"date-parts":[[2003,2]]}}}